Modification of human airway smooth muscle reactivity by drugs that interfere with arachidonic acid metabolism.

PubWeight™: 0.87‹?›

🔗 View Article (PMC 2044666)

Published in Br J Pharmacol on December 01, 1982

Authors

J J Adcock, L G Garland

Articles by these authors

Cromoglycate and other antiallergic drugs: a possible mechanism of action. Br Med J (1976) 2.13

Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo. Br J Pharmacol (1988) 2.02

A possible role for cyclic AMP in the regulation of histamine secretion and the action of cromoglycate. Biochem Pharmacol (1975) 1.80

Desensitization in the process of histamine secretion induced by antigen and dextran. J Physiol (1974) 1.74

A possible role for lipoxygenase products as regulators of airway smooth muscle reactivity. Br J Pharmacol (1980) 1.56

Differential histamine release by dextran and the ionophore A23187: the actions of inhibitors. Int Arch Allergy Appl Immunol (1976) 1.52

Doxantrazole, an antiallergic agent orally effective in man. Lancet (1975) 1.40

Phospholipase D activation is functionally linked to superoxide generation in the human neutrophil. Biochem J (1989) 1.28

Tyrosine phosphorylation is involved in receptor coupling to phospholipase D but not phospholipase C in the human neutrophil. Biochem J (1992) 1.28

The mechanism of enhancement by fatty acid hydroperoxides of anaphylactic mediator release. Prostaglandins (1978) 1.26

Enhancement of anaphylactic mediator release from guinea-pig perfused lungs by fatty acid hydroperoxides. Prostaglandins (1978) 1.24

Demethoxyviridin and wortmannin block phospholipase C and D activation in the human neutrophil. Br J Pharmacol (1991) 1.22

Inhibition by cromoglycate of histamine release from rat peritoneal mast cells induced by mixtures of dextran, phosphatidyl serine and calcium ions. Br J Pharmacol (1974) 1.20

A device for the rapid measurement of rat foot volume. J Pharm Pharmacol (1968) 1.19

Role of oxygen radicals and arachidonic acid metabolites in the reverse passive Arthus reaction and carrageenin paw oedema in the rat. Br J Pharmacol (1993) 1.13

The temporal relationship between phospholipase activation, diradylglycerol formation and superoxide production in the human neutrophil. Biochem J (1990) 1.13

Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: effects on bronchial anaphylaxis in anaesthetized guinea-pigs. Br J Pharmacol (1988) 1.09

Effects of aerosol-applied capsaicin, histamine and prostaglandin E2 on airway sensory receptors of anaesthetized cats. J Physiol (1993) 1.07

Receptor-coupled phospholipase D and its inhibition. Trends Pharmacol Sci (1991) 1.06

Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: effects on acute inflammatory responses. Br J Pharmacol (1988) 1.04

A novel and sensitive assay for phospholipase D in intact cells. FEBS Lett (1990) 1.03

Leukotriene antagonists and inhibitors of leukotriene biosynthesis as potential therapeutic agents. Prog Drug Res (1991) 0.93

Effect of cromoglycate on anaphylactic histamine release from rat peritoneal mast cells. Br J Pharmacol (1973) 0.89

The role of cell-fixed calcium in histamine release by compound 48/80. Br J Pharmacol (1979) 0.88

Involvement of central 5-HT1A receptors in the reflex activation of pulmonary vagal motoneurones by inhaled capsaicin in anaesthetized cats. Br J Pharmacol (1996) 0.88

Modulation of bronchoconstrictor responses to histamine in pithed guinea-pigs by sympathetic nerve stimulation. Br J Pharmacol (1982) 0.87

A quantitative investigation into the dependence of Ca2+ mobilisation on changes in inositol 1,4,5-trisphosphate levels in the stimulated neutrophil. Br J Pharmacol (1991) 0.87

The role of central 5-HT receptors in the bronchoconstriction evoked by inhaled capsaicin in anaesthetised guinea-pigs. Neuropharmacology (1998) 0.87

The generation and metabolism of leukotrienes in the ionophore-stimulated blood of normal and asthmatic subjects. Pulm Pharmacol (1990) 0.86

A possible modulatory role for prostacyclin (PGI2) INIgGa-induced release of slow-reacting substance of anaphylaxis in rats. Br J Pharmacol (1977) 0.85

Inhibition of airway hyper-responsiveness by TRPV1 antagonists (SB-705498 and PF-04065463) in the unanaesthetized, ovalbumin-sensitized guinea pig. Br J Pharmacol (2012) 0.85

Ca2+-independent binding of [3H]phorbol dibutyrate to protein kinase C is supported by protamine and other polycations. Biochem J (1988) 0.85

A method for the comparative assessment of antioxidants as peroxyl radical scavengers. Biochem Pharmacol (1989) 0.84

Inhibition of phorbol ester stimulated superoxide production by 1-oleoyl-2-acetyl-sn-glycerol (OAG); fact or artefact? FEBS Lett (1986) 0.84

The effects of a novel series of selective inhibitors of arachidonate 5-lipoxygenase on anaphylactic and inflammatory responses. Ann N Y Acad Sci (1988) 0.83

Evidence that a second stereochemical centre in diacylglycerols defines interaction at the recognition site on protein kinase C. FEBS Lett (1988) 0.81

A phorbol ester and a daphnane ester stimulate a calcium-independent kinase activity from human mononuclear cells. FEBS Lett (1989) 0.81

Phospholipase D: regulation and functional significance. Adv Pharmacol (1993) 0.80

Inhibition by cromoglycate of histamine release induced by dextran plus phosphatidyl serine. Br J Pharmacol (1973) 0.80

Stimulation and inhibition of secretion by phorbol myristate acetate in different cell types. Biochem Biophys Res Commun (1985) 0.80

Role of c-lyn in the functional effects of GM-CSF on human neutrophils. Biochem Soc Trans (1995) 0.80

The relationship between energy metabolism and the action of inhibitors of histamine release. Br J Pharmacol (1977) 0.78

Decrease of cellular ATP by dihexanoylglycerol may limit responses to protein kinase C activation. FEBS Lett (1987) 0.78

The effect of 15-HPETE on airway responsiveness and pulmonary cell recruitment in rabbits. Br J Pharmacol (1997) 0.78

Selectivity of protein kinase inhibitors in human intact platelets. Cell Signal (1990) 0.78

Hydroxamic acids and hydroxyureas as novel, selective 5-lipoxygenase inhibitors for possible use in asthma. Agents Actions Suppl (1991) 0.77

Inhibition of 5-lipoxygenase: development of hydroxamic acids and hydroxyureas as potential therapeutic agents. Adv Prostaglandin Thromboxane Leukot Res (1991) 0.77

The extraneuronal O-methylation of 3H-(+)isoprenaline by guinea-pig tracheal rings in vitro. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.77

Separation of IgE from IgG subclasses using staphylococcal protein A. Int Arch Allergy Appl Immunol (1978) 0.77

New approaches to the attenuation of sensory reflexes in airway inflammation. Agents Actions Suppl (1991) 0.76

Effect of BW443C81, a novel opioid, on non-cholinergic bronchoconstrictor responses and neurogenic plasma extravasation in the guinea pig. Agents Actions (1992) 0.76

Capsaicin-induced bronchoconstriction in the guinea-pig: contribution of vagal cholinergic reflexes, local axon reflexes and their modulation by BW443C81. Br J Pharmacol (1992) 0.76

Proceedings: An improved apparatus for automatic sampling and the control of isolated preparations. Br J Pharmacol (1974) 0.75

Proceedings: Effects of phenobarbitone and leptazol on rat brain lysosomes. Br J Pharmacol (1972) 0.75

Mechanism of A23187 induced histamine release [proceedings]. Br J Pharmacol (1978) 0.75

The effects of a 5-lipoxygenase inhibitor, BW A4C, on the acute response to inhaled PAF in man. Ann N Y Acad Sci (1991) 0.75

Properties of separated neurons and glia. Lab Pract (1970) 0.75

Interaction between barium, strontium and calcium in histamine release by compound 48/80. Eur J Pharmacol (1978) 0.75

Development of a novel series of trialkoxyaryl derivatives as specific and competitive antagonists of platelet activating factor. J Med Chem (1995) 0.75

Central 5-HT1A and 5-HT1D receptors modulate reflex bronchoconstriction in guinea-pigs. Pulm Pharmacol (1997) 0.75

A commentary on the inhibition by retinoids of leukotriene B4 production in leukocytes. FEBS Lett (1987) 0.75

Selective 5-lipoxygenase inhibitor BW A4C does not influence progression of tissue injury in a canine model of regional myocardial ischaemia and reperfusion. J Cardiovasc Pharmacol (1991) 0.75